VIRAL GENETICS INC /DE/·4

Oct 22, 2:29 PM ET

KARAGEOZIAN HAMPAR 4

4 · VIRAL GENETICS INC /DE/ · Filed Oct 22, 2004

Insider Transaction Report

Form 4
Period: 2004-08-05
KARAGEOZIAN HAMPAR
Director10% Owner
Transactions
  • Gift

    common stock

    [F1][F2]
    2004-09-29100,00010,276,221 total
  • Award

    common stock

    [F3]
    2004-09-20+4,934,71210,276,221 total
  • Other

    convertible note

    [F4][F6][F5]
    2004-08-05
    Exercise: $0.30Exp: 2008-05-31common stock (2,759,728 underlying)
  • Award

    common stock warrant

    [F7][F5]
    2004-09-20+4,934,7124,934,712 total
    Exercise: $0.40Exp: 2009-09-19common stock (4,934,712 underlying)
  • Award

    stock option

    [F8][F6][F5]
    2004-09-20+99,85899,858 total
    Exercise: $0.52Exp: 2006-09-19common stock (99,858 underlying)
  • Award

    stock option

    [F8][F6][F5]
    2004-09-20+49,92949,929 total
    Exercise: $0.38Exp: 2006-09-19common stock (49,929 underlying)
  • Award

    stock option

    [F8][F6][F5]
    2004-09-20+49,92949,929 total
    Exercise: $0.65Exp: 2006-09-19common stock (49,929 underlying)
  • Award

    stock option

    [F8][F6][F5]
    2004-09-20+49,92949,929 total
    Exercise: $0.58Exp: 2006-09-19common stock (49,929 underlying)
Footnotes (8)
  • [F1]gifted to child
  • [F2]the high bid price of the common stock of Viral Genetics, Inc., on the over-the-counter market on the date of gifting was $0.44
  • [F3]Received in exchange for capital stock of Therapeutic Genetic, Inc., in connection with merger of Therapeutic Genetic, Inc. into subsidiary of Viral Genetics, Inc. On September 20, 2004, the high bid price for Viral Genetics, Inc. common stock in the over-the-counter market was $0.38.
  • [F4]note assigned to Best Investments, Inc.
  • [F5]immediately
  • [F6]not applicable
  • [F7]The warrants were issued with the common stock of Viral Genetics, Inc., in the merger transaction that resulted in the acquisition of Therapeutic Genetic, Inc.
  • [F8]All stock options with a transaction date of 09/20/2004 are options originally granted to Therapeutic Genetic, Inc. and distributed by Therapeutic Genetic, Inc. to its shareholders for no consideration immediately prior to the merger of Therapeutic Genetic, Inc. with the subsidiary of Viral Genetics, Inc.
Signature
Hampar Karageozian|2004-10-22

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT